ArticleJournal of experimental & clinical cancer research : CR2026

SRSF2 mutations drive daunorubicin resistance in acute myeloid leukemia via THBS1 stabilization.

Wu Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.